Donor Egg IVF Treatment Market By Cycle Type (Fresh Donor Egg IVF Cycle and Frozen Donor Egg IVF Cycle), By End User (Fertility Clinic, Hospital and Clinical Research Institute) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

The donor egg IVF treatment market is expected to reach $3,676.8 million by 2027, up from $1,782.1 million in 2018, indicating moderate growth at an 8.4% compound annual growth rate (CAGR) from 2019 to 2027.

In the last two decades, there has been a paradigm shift in society that has had a major influence on the consistently growing infertility rate. A significant rise in working women, delayed marriages, advanced maternal age, etc., provides a positive impetus for the donor egg IVF treatment market.

Market Synopsis

The fresh donor egg IVF cycle market is derived from high pregnancy success rates and efficiency in retrieving viable embryos.

Fresh donor egg IVF cycles are reigning in the cycle-type segment of the donor egg IVF treatment market. The advantages associated with a fresh donor egg IVF treatment cycle are the high success rate associated with pregnancy and the efficient method of retrieving viable embryos.

The limitation associated with this cycle type is the long waiting period. The frozen donor egg IVF cycle market is gaining traction on account of effective screening and consistent cohorts ready to be shipped, thawed, and used as per a client's schedule. Changes in lifestyle and family planning motivate people to freeze eggs for future children and siblings.

The fertility clinics market is growing due to technological advancements in IVF treatment protocols and state-of-the-art capital equipment.

Fertility clinics are dominating the end-user segment of the donor egg IVF treatment market. Inherent features such as technological advancement in IVF treatment protocols such as egg freezing, hatching, vitrification, intrafallopian gamete transfer (GIFT), etc., provide the necessary impetus for the market growth of fertility clinics worldwide.

Healthcare organizations in developed countries are providing significant financial assistance to establish IVF treatment centers in hospitals to serve people in remote areas.

The rising prevalence of menopause and rising public health awareness about infertility drive market growth in North America.

North America, with a market share of 34%, is the leading regional segment for the donor egg IVF treatment market. The rising prevalence of menopause is the primary cause of its dominance. As per the statistics provided by the American Congress of Obstetricians and Gynecologists, approximately 2 million women reach early menopause annually. Increasing public health awareness related to infertility will propel market growth in the region.

Europe accounts for 32% of the market share, owing to a change in lifestyle that prioritizes a professional career over a personal life and, hence, opts for late-stage pregnancy induced via IVF treatment. Asia Pacific is representing 24% market growth on account of a significant rise in fertility clinics and increasing fertility tourism as IVF treatment is now available at an affordable price.

Periods of History and Forecast

This research report presents the analysis of each segment from 2017 to 2027,considering 2018as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market segmentation for the scope of the report is done by cycle type, end user, and geography.

Pharmaceutical companies specializing in providing IVF treatment services are Cook Medical, Inc., EMD Serono, Inc., Flinders Reproductive Medicine Pty. Ltd., Fertility First, Genea Oxford Fertility Limited, OvaScience, Procrea Fertility, Progyny, Inc., ReproMed, and Vitrolife AB.

Key questions are answered in this report.

• Which major players are competing in the donor egg IVF treatment market?
• What are the organic and inorganic market growth strategies to determine the latest market trend?
• What are the different factors responsible for infertility in women?
• Which factors are related to the growing popularity of fresh donor eggs in IVF cycles?
• What advanced IVF treatment protocols are available in fertility clinics?
• What will be the market size and CAGR for the Asia-Pacific region during the forecast period?

Frequently Asked Question: